BSE filing, NSE: AEGISLOG. Summary written from the filing by ALFA Finder's alert engine.
Aegis Logistics Ltd: key numbers
- Share price
- ₹1,193.30
- Market cap
- ₹41,885 Cr
- Revenue (annual)
- ₹8,333 Cr
- Net profit (annual)
- ₹898.1 Cr
- P/E (TTM)
- 31.4×Sector 18.2×
- Promoter holding
- 58.10%+0.00% QoQ
- FII holding
- 19.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aegis Logistics Ltd
All →Aegis Logistics Earnings Call Transcript: Key Takeaways
Record H1 profit: PAT ₹866 Cr (+108%) on revenue ₹4,570 Cr (+14%); Q2 revenue fell to ₹2,213 Cr from ₹2,294 Cr, profit growth driven by margins.
Aegis Logistics Q2 FY27 Results: Net Profit ₹320.5 Cr, Up 31.4% YoY
Aegis Logistics Ltd reported revenue from operations of ₹2,213 Cr (-3.5% YoY) and net profit of ₹320.5 Cr (+31.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹320.5 Cr · +31.4% YoY
Aegis Logistics Credit Rating
CARE Ratings updated Aegis Logistics' credit ratings, placing its Long Term Bank Facilities on 'Rating Watch with Developing Implications' and reaffirming Short Term Bank Facilities.
Aegis Logistics Board Meeting Date
Aegis Logistics will hold a board meeting on October 26, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Aegis Logistics Annual General Meeting
Aegis Logistics Limited held its Extra-Ordinary General Meeting on October 21, 2026. Shareholders considered resolutions concerning borrowing limits and fund-raising activities.
Aegis Logistics Other Announcement
Aegis Logistics Limited has received an independent ESG rating of 69 from NSE Sustainability Ratings & Analytics Limited, based on publicly available data.
Other price movement clarification announcements
All →Marsons Price Movement Clarification
Marsons Ltd. replied to an exchange price-movement query stating no undisclosed information exists. The company affirmed compliance with LODR and no future disclosure is pending.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.
Yaap Digital Price Movement Clarification
Yaap Digital told NSE no undisclosed event explains its recent share price movement. The Company confirmed all disclosures are timely and the movement is market-driven.
Quality RO Industries Price Movement Clarification
Quality RO Industries clarified BSE's surveillance query on share price movement, stating it was purely market-driven with no undisclosed material information.
Mahanagar Telephone Nigam Price Movement Clarification
MTNL responded to an NSE surveillance query on a volume spurt, stating no undisclosed material information exists. The share price movement is attributed to market conditions alone.
CIAN Agro Industries & Infrastructure Price Movement Clarification
CIAN Agro clarified to BSE that its recent significant share price movement is driven by market conditions. Management says it has no knowledge of the reasons and will keep complying with Regulation 30.